U.S. Markets closed

Innospec Initiates Site Construction for DRA Manufacturing

Zacks Equity Research
1 / 2

CB Financial Services (CBFV) Q3 Earnings Preview: What to Look Out For

CB Financial Services (CBFV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Innospec Inc. IOSP has started construction on its new facility to make Drag Reducing Agents (DRAs). The site, located at Pleasanton, TX, is an extension of the existing Innospec site. The project is well advanced and the company expects beneficial production in the second half of 2018.

Besides being a fast-growing, exciting, cutting-edge technology, DRAs offer improved productivity as well as low costs for customers. This latest addition is complementary to the company’s existing portfolio that will allow it to serve its customers globally.

These products reduce the turbulent flow of liquids in a cost-effective manner to improve pipeline throughput and reduce the energy required for pumping. The technology can be applied to crude oils and to fuels including diesel.

Shares of Innospec have gained 22.3% over a year, outperforming the industry’s 15% gain.


The company reported adjusted earnings of $1.02 per share for the first quarter of 2018, beating the Zacks Consensus Estimate of 98 cents.  Revenues went up 23% year over year to $360.7 million in the quarter.

Innospec is seeing healthy customer activity across all of its core businesses. The company said that it will remain focused on further improving margins in Performance Chemicals and other strategic businesses to boost profitability. Innospec expects its margin-improvement programs to deliver enhanced profitability later this year.

Innospec Inc. Price and Consensus

Innospec Inc. Price and Consensus | Innospec Inc. Quote

Zacks Rank & Other Stocks to Consider

Innospec is a Zacks Rank #2 (Buy) stock.

Some other top-ranked companies in the basic materials space worth considering are FMC Corporation FMC, Huntsman Corporation HUN and The Chemours Company CC. All three stocks sport a Zacks Rank #1 (Strong Buy).  You can see the complete list of today’s Zacks #1 Rank stocks here.

FMC Corp has an expected long-term earnings growth rate of 13.6%.  Its shares have gained around 22.4% over a year.

Huntsman has an expected long-term earnings growth rate of 8.3%.  Its shares have moved up around 24.8% over a year.

Chemours has an expected long-term earnings growth rate of 15.5%.  Its shares have gained around 20.2% over a year.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
FMC Corporation (FMC) : Free Stock Analysis Report
 
Huntsman Corporation (HUN) : Free Stock Analysis Report
 
Chemours Company (The) (CC) : Free Stock Analysis Report
 
Innospec Inc. (IOSP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research